Lineage Cell Therapeutics Inc

$LCTX
Institutional coverage

130 13F filers hold $LCTX.

13F holders
130
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

4 holders · Q1 2026

$LCTX is held by 4 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.02%, with an average of 0.01% of portfolio. Largest holder: ELCO Management Co., LLC at 0.02%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 130 · Source: 13F-HR
01
Zions Bancorporation, National Association
5.52% of portfolio
49,560,992 sh
02
Riverstone Advisors, LLC
3.77% of portfolio
6,729,599 sh
03
Atlantic Edge Private Wealth Management, LLC
6,715,653 sh
04
Banyan Capital Management, Inc.
6,058,030 sh
05
Evergreen Capital Management LLC
5,561,374 sh
06
Raffles Associates LP
9.00% of portfolio
5,387,788 sh
07
Strategy Asset Managers LLC
7.35% of portfolio
5,362,788 sh
08
Highland Capital Management, LLC
0.03% of portfolio
4,600,000 sh
09
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
0.01% of portfolio
4,600,000 sh
10
HWG Holdings LP
0.09% of portfolio
3,182,799 sh
See all 130 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $LCTX in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $LCTX in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 11:51 UTC.